Paper6286014
Changes in cell surface antigen expression during hemopoietic differentiation.
Sieff C and 5 others. Blood, 1982. Cited by 284 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Changes in cell surface antigen expression during hemopoietic differentiation. Papers, record 6286014. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6286014
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antigens, Surface | Major topic |
| Hematopoietic Stem Cells | Major topic |
| ABO Blood-Group System | |
| Anion Exchange Protein 1, Erythrocyte | |
| Antibodies, Monoclonal | |
| Blood Proteins | |
| Bone Marrow Cells | |
| Cell Differentiation | |
| HLA-DR Antigens | |
| Histocompatibility Antigens Class II | |
| Humans | |
| I Blood-Group System | |
| Receptors, Cell Surface | |
| Receptors, Transferrin |
Source PubMed
Cited by42
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 284 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 39135854 | Review of ABO Expression and Variations based on Transcriptional Regulation of the ABO Blood Group Gene. | Transfus Med Hemother | 2024 | https://conductscience.org/library/papers/39135854 | PubMed |
| 39135851 | Role of MiRNA in the Regulation of Blood Group Expression. | Transfus Med Hemother | 2024 | https://conductscience.org/library/papers/39135851 | PubMed |
| 38228962 | Immune System Influence on Hematopoietic Stem Cells and Leukemia Development. | Adv Exp Med Biol | 2023 | https://conductscience.org/library/papers/38228962 | PubMed |
| 37932129 | Iron, Copper, and Selenium: Cancer's Thing for Redox Bling. | Cold Spring Harb Perspect Med | 2024 | https://conductscience.org/library/papers/37932129 | PubMed |
| 35523139 | Antigen presentation safeguards the integrity of the hematopoietic stem cell pool. | Cell Stem Cell | 2022 | https://conductscience.org/library/papers/35523139 | PubMed |
| 34021930 | Comprehensive phenotyping of erythropoiesis in human bone marrow: Evaluation of normal and ineffective erythropoiesis. | Am J Hematol | 2021 | https://conductscience.org/library/papers/34021930 | PubMed |
| 32216153 | Human ABO gene transcriptional regulation. | Transfusion | 2020 | https://conductscience.org/library/papers/32216153 | PubMed |
| 31632073 | Pathophysiologic Mechanisms And Management Of Large Granular Lymphocytic Leukemia Associated Pure Red Cell Aplasia. | Onco Targets Ther | 2019 | https://conductscience.org/library/papers/31632073 | PubMed |
| 28212192 | Genetic control of erythropoiesis. | Curr Opin Hematol | 2017 | https://conductscience.org/library/papers/28212192 | PubMed |
| 27999737 | Immunotherapies targeting CD38 in Multiple Myeloma. | Oncoimmunology | 2016 | https://conductscience.org/library/papers/27999737 | PubMed |
| 26462019 | YK-4-279 effectively antagonizes EWS-FLI1 induced leukemia in a transgenic mouse model. | Oncotarget | 2015 | https://conductscience.org/library/papers/26462019 | PubMed |
| 25339359 | Isolation and transcriptome analyses of human erythroid progenitors: BFU-E and CFU-E. | Blood | 2014 | https://conductscience.org/library/papers/25339359 | PubMed |
| 24573305 | Transferrin receptor-mediated endocytosis: a useful target for cancer therapy. | J Membr Biol | 2014 | https://conductscience.org/library/papers/24573305 | PubMed |
| 21411527 | Natural killer cells recognize friend retrovirus-infected erythroid progenitor cells through NKG2D-RAE-1 interactions In Vivo. | J Virol | 2011 | https://conductscience.org/library/papers/21411527 | PubMed |
| 20065081 | Rac1 and Rac2 GTPases are necessary for early erythropoietic expansion in the bone marrow but not in the spleen. | Haematologica | 2010 | https://conductscience.org/library/papers/20065081 | PubMed |
| 17898788 | Recent advances in adult T-cell leukemia therapy: focus on a new anti-transferrin receptor monoclonal antibody. | Leukemia | 2008 | https://conductscience.org/library/papers/17898788 | PubMed |
| 16804109 | Molecular events contributing to cell death in malignant human hematopoietic cells elicited by an IgG3-avidin fusion protein targeting the transferrin receptor. | Blood | 2006 | https://conductscience.org/library/papers/16804109 | PubMed |
| 15047822 | Impact of human cytomegalovirus latent infection on myeloid progenitor cell gene expression. | J Virol | 2004 | https://conductscience.org/library/papers/15047822 | PubMed |
| 12803302 | Biological and mechanical quality of red blood cells cultured from human umbilical cord blood stem cells. | Med Biol Eng Comput | 2003 | https://conductscience.org/library/papers/12803302 | PubMed |
| 10790365 | MafB is an inducer of monocytic differentiation. | EMBO J | 2000 | https://conductscience.org/library/papers/10790365 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| HLA-A | 3105 | PubTator's text mining | https://conductscience.org/library/genes/3105 | NCBI Gene |
| TFRC | 7037 | PubTator's text mining | https://conductscience.org/library/genes/7037 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/6286014
GET https://conductscience.org/api/papers/v1/6286014/cited_by?page=2